Drawing for PEMA

USPTO serial 85978456

PEMA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
ORTIGA PALMER, RAMONA
Law office
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PEMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles T.J. Weigell

CHARLES T.J. WEIGELL FROSS ZELNICK LEHRMAN & ZISSU, P.C.866 UNITED NATIONS PLZNEW YORK, NY 10017-1822UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for use in the treatment of varicose veins; pharmaceutical preparations in the form of foams or for use in producing foams for use in the treatment of varicose veins; pharmaceutical preparations, including preparations in the forms of foams or for use in preparing foams, for use in sclerotherapy, for use in the treatment of diseases and conditions in the fields of sclerotherapy, phlebology, angiology and proctology, for treatment of esophageal varices and hydroceles, and for treatment of varicose veins and arterio-venous malformations; pharmaceutical preparations, namely, therapeutic microfoams for use in the treatment of sclerotherapy of veins and in the fields of phlebology, proctology and angiologyACTIVE—
010Surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology and proctology, sterilization treatment or for treatment of varicose veins, arterio-venous malformations, esophageal varices and hydroceles; medical devices for assessing the physical characteristics of, for intravenous administration, and for monitoring the position and effect of foam in the human body used in sclerotherapy, phlebology, angiology and proctology, sterilization treatment or for treatment of varicose veins, arterio-venous malformations, esophageal varices and hydroceles, including foam transfer units including transparent chambers for viewing foam; medical diagnostic devices for use in all of the above medical conditions, namely, electromagnetic, medical diagnostic imaging apparatus; surgical and medical apparatus for producing foams for use in sclerotherapy of veins, including canisters and disposable cassettes for generating foam; surgical and medical apparatus for use in the treatment of varicose veins and venous malformations using sclerosing foams, including devices for assessing the physical characteristics of such foams, devices for intravenous administration of foam and devices for monitoring the position and effect of foam in the human body, including cannula, catheter and syringes for administering foamACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 27, 2013MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Jun 27, 2013ABN1ABANDONMENT - EXPRESS MAILED—
Jun 26, 2013EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 19, 2013CNSIINQUIRY AS TO SUSPENSION MAILED—
Jun 19, 2013CNSISUSPENSION INQUIRY WRITTEN—
May 19, 2013RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 20, 2013ATRVATTORNEY REVIEW COMPLETED—
Jan 23, 2013DPCCDIVISIONAL PROCESSING COMPLETE—
Jan 22, 2013DRRRDIVISIONAL REQUEST RECEIVED—
Jan 22, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 22, 2013FAXXFAX RECEIVED—
Jan 16, 2013ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 15, 2012CNSLLETTER OF SUSPENSION MAILED—
Nov 14, 2012CNSLSUSPENSION LETTER WRITTEN—
Oct 17, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 17, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2012ALIEASSIGNED TO LIE—
Sep 28, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2012CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2012DOCKASSIGNED TO EXAMINER—
Jan 11, 2012TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jan 11, 2012PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 21, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance